| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 7 | -532,053 | 100% | $21.00 | -$11,171,069 |
| Net | -7 | -532,053 | -100% | -$11,171,069 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 10%+ Owner | $345,672,360 | 18 Feb 2025 | ||
| Terry J. Rosen | Chief Executive Officer, Director | $53,293,626 | -$1,203,959 | -2.2% | 23 Jan 2026 |
| Juan C. Jaen | President | $30,961,174 | -$6,309,802 | -17% | 23 Jan 2026 |
| Yasunori Kaneko | Director | $7,732,309 | 10 Jun 2025 | ||
| Jennifer Jarrett | Chief Operating Officer | $5,437,414 | -$2,171,347 | -29% | 23 Jan 2026 |
| Carolyn C. Tang | General Counsel | $3,544,331 | -$318,496 | -8.2% | 23 Jan 2026 |
| II Robert C. Goeltz | Chief Financial Officer | $2,190,548 | -$656,925 | -23% | 23 Jan 2026 |
| Richard Markus | Chief Medical Officer | $2,136,288 | -$210,144 | -9% | 23 Jan 2026 |
| Nuyten Dimitry SA | Chief Medical Officer | $1,407,289 | 15 Dec 2024 | ||
| Kathryn E. Falberg | Director | $1,386,132 | 10 Jun 2025 | ||
| Alexander Azoy | Chief Accounting Officer | $943,215 | -$300,395 | -24% | 23 Jan 2026 |
| David L. Lacey | Director | $576,130 | 10 Jun 2025 | ||
| Antoni Ribas | Director | $423,888 | 10 Jun 2025 | ||
| William Grossman | Chief Medical Officer | $414,460 | 16 Jun 2021 | ||
| Andrew J. Perlman | Director | $346,115 | 10 Jun 2025 | ||
| Patrick Machado | Director | $313,432 | 10 Jun 2025 | ||
| Nicole Lambert | Director | $302,876 | 10 Jun 2025 | ||
| Johanna Mercier | Director | $0 | 29 Jan 2024 | ||
| Dietmar Berger | Director | $0 | 06 Feb 2025 | ||
| Linda Slanec Higgins | Director | 10 Aug 2021 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Richard Markus | RCUS | Common Stock | Award | 36.6% | 24,000 | 89,647 | 23 Jan 2026 | Direct | ||
| Richard Markus | RCUS | Stock Option (right to buy) | Award | 96,000 | 96,000 | 23 Jan 2026 | Direct | |||
| Carolyn C. Tang | RCUS | Common Stock | Award | 19.2% | 24,000 | 148,734 | 23 Jan 2026 | Direct | ||
| Carolyn C. Tang | RCUS | Stock Option (right to buy) | Award | 96,000 | 96,000 | 23 Jan 2026 | Direct | |||
| Alexander Azoy | RCUS | Common Stock | Award | 113.6% | 21,050 | 39,581 | 23 Jan 2026 | Direct | ||
| Alexander Azoy | RCUS | Stock Option (right to buy) | Award | 14,050 | 14,050 | 23 Jan 2026 | Direct | |||
| Jennifer Jarrett | RCUS | Common Stock | Award | 16.1% | 31,000 | 224,024 | 23 Jan 2026 | Direct | ||
| Jennifer Jarrett | RCUS | Stock Option (right to buy) | Award | 126,000 | 126,000 | 23 Jan 2026 | Direct | |||
| II Robert C. Goeltz | RCUS | Common Stock | Award | 35.3% | 24,000 | 91,924 | 23 Jan 2026 | Direct | ||
| II Robert C. Goeltz | RCUS | Stock Option (right to buy) | Award | 96,000 | 96,000 | 23 Jan 2026 | Direct | |||
| Juan C. Jaen | RCUS | Common Stock | Award | 8.96% | 31,000 | 377,012 | 23 Jan 2026 | Direct | ||
| Juan C. Jaen | RCUS | Stock Option (right to buy) | Award | 126,000 | 126,000 | 23 Jan 2026 | Direct | |||
| Terry J. Rosen | RCUS | Common Stock | Award | 3.66% | 79,000 | 2,236,409 | 23 Jan 2026 | Direct | ||
| Terry J. Rosen | RCUS | Stock Option (right to buy) | Award | 315,000 | 315,000 | 23 Jan 2026 | Direct | |||
| Terry J. Rosen | RCUS | Common Stock | Gift | -1.6% | -35,000 | 2,157,409 | 08 Jan 2026 | Direct | ||
| Juan C. Jaen | RCUS | Common Stock | Sale | -3.34% | $681,342 | $21.41 | -31,823 | 922,240 | 05 Jan 2026 | By Trust |
| II Robert C. Goeltz | RCUS | Common Stock | Sale | -8.8% | $153,186 | $23.38 | -6,552 | 67,924 | 31 Dec 2025 | Direct |
| Terry J. Rosen | RCUS | Common Stock | Gift | -0.11% | -2,400 | 2,192,409 | 30 Dec 2025 | Direct | ||
| Alexander Azoy | RCUS | Common Stock | Sale | -19% | $96,614 | $22.25 | -4,343 | 18,531 | 18 Dec 2025 | Direct |
| Carolyn C. Tang | RCUS | Common Stock | Sale | -5.18% | $150,906 | $22.16 | -6,810 | 124,734 | 17 Dec 2025 | Direct |
| Richard Markus | RCUS | Common Stock | Sale | -6.41% | $99,585 | $22.16 | -4,494 | 65,647 | 17 Dec 2025 | Direct |
| Alexander Azoy | RCUS | Common Stock | Sale | -8.46% | $46,823 | $22.16 | -2,113 | 22,874 | 17 Dec 2025 | Direct |
| II Robert C. Goeltz | RCUS | Common Stock | Sale | -7.41% | $132,071 | $22.16 | -5,960 | 74,476 | 17 Dec 2025 | Direct |
| Jennifer Jarrett | RCUS | Common Stock | Sale | -4.92% | $221,218 | $22.16 | -9,983 | 193,024 | 17 Dec 2025 | Direct |
| Juan C. Jaen | RCUS | Common Stock | Sale | -2.8% | $221,218 | $22.16 | -9,983 | 346,012 | 17 Dec 2025 | Direct |
| Terry J. Rosen | RCUS | Common Stock | Sale | -1.16% | $570,474 | $22.16 | -25,744 | 2,194,809 | 17 Dec 2025 | Direct |
| Carolyn C. Tang | RCUS | Common Stock | Sale | -5.5% | $167,590 | $21.88 | -7,658 | 131,544 | 16 Dec 2025 | Direct |
| Richard Markus | RCUS | Common Stock | Sale | -6.72% | $110,559 | $21.88 | -5,052 | 70,141 | 16 Dec 2025 | Direct |
| Alexander Azoy | RCUS | Common Stock | Sale | -8.68% | $51,997 | $21.88 | -2,376 | 24,987 | 16 Dec 2025 | Direct |
| II Robert C. Goeltz | RCUS | Common Stock | Sale | -7.69% | $146,669 | $21.88 | -6,702 | 80,436 | 16 Dec 2025 | Direct |
| Jennifer Jarrett | RCUS | Common Stock | Sale | -5.24% | $245,651 | $21.88 | -11,225 | 203,007 | 16 Dec 2025 | Direct |
| Juan C. Jaen | RCUS | Common Stock | Sale | -3.06% | $245,651 | $21.88 | -11,225 | 355,995 | 16 Dec 2025 | Direct |
| Terry J. Rosen | RCUS | Common Stock | Sale | -1.29% | $633,485 | $21.88 | -28,947 | 2,220,553 | 16 Dec 2025 | Direct |
| Juan C. Jaen | RCUS | Common Stock | Sale | -8% | $2,050,599 | $24.71 | -82,997 | 954,063 | 04 Dec 2025 | By Trust |
| Alexander Azoy | RCUS | Common Stock | Sale | -6.49% | $49,400 | $26.00 | -1,900 | 27,363 | 26 Nov 2025 | Direct |
| Alexander Azoy | RCUS | Common Stock | Options Exercise | 6.94% | 1,900 | 29,263 | 26 Nov 2025 | Direct | ||
| Alexander Azoy | RCUS | Stock Option (right to buy) | Options Exercise | -16.7% | -1,900 | 9,500 | 26 Nov 2025 | Direct | ||
| II Robert C. Goeltz | RCUS | Common Stock | Sale | -5.43% | $125,000 | $25.00 | -5,000 | 87,138 | 26 Nov 2025 | Direct |
| Juan C. Jaen | RCUS | Common Stock | Sale | -0.48% | $99,738 | $19.75 | -5,050 | 1,037,060 | 18 Nov 2025 | By Trust |
| Juan C. Jaen | RCUS | Common Stock | Sale | -4.14% | $913,027 | $20.31 | -44,950 | 1,042,110 | 17 Nov 2025 | By Trust |
| Jennifer Jarrett | RCUS | Common Stock | Sale | -19% | $954,066 | $18.97 | -50,291 | 214,232 | 07 Nov 2025 | Direct |
| Jennifer Jarrett | RCUS | Common Stock | Options Exercise | 23.5% | 50,291 | 264,523 | 07 Nov 2025 | Direct | ||
| Jennifer Jarrett | RCUS | Stock Option (Right to Buy) | Options Exercise | -38.4% | -50,291 | 80,583 | 07 Nov 2025 | Direct | ||
| Juan C. Jaen | RCUS | Common Stock | Sale | -0.4% | $87,650 | $20.32 | -4,314 | 1,087,060 | 30 Oct 2025 | By Trust |
| Juan C. Jaen | RCUS | Common Stock | Sale | -6.66% | $1,626,634 | $20.90 | -77,840 | 1,091,374 | 29 Oct 2025 | By Trust |
| Juan C. Jaen | RCUS | Common Stock | Sale | -1.6% | $383,944 | $20.19 | -19,019 | 1,169,214 | 28 Oct 2025 | By Trust |
| II Robert C. Goeltz | RCUS | Common Stock | Sale | -5.15% | $100,000 | $20.00 | -5,000 | 92,138 | 28 Oct 2025 | Direct |
| Jennifer Jarrett | RCUS | Common Stock | Sale | -15% | $568,611 | $15.05 | -37,792 | 214,232 | 08 Oct 2025 | Direct |
| Jennifer Jarrett | RCUS | Common Stock | Options Exercise | 17.6% | 37,792 | 252,024 | 08 Oct 2025 | Direct | ||
| Jennifer Jarrett | RCUS | Stock Option (Right to Buy) | Options Exercise | -22.4% | -37,792 | 130,874 | 08 Oct 2025 | Direct |